Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Circulating Tumor Cells Market by the end of 2030?

The circulating tumor cells market size has expanded considerably in recent years. It is forecast to grow from $13.27 billion in 2025 to $14.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. The historical increase can be linked to higher cancer incidence rates, the expansion of oncology research initiatives, the broader application of blood-based diagnostics, an increasing preference for minimally invasive testing approaches, and the accessibility of advanced laboratory technologies.

The circulating tumor cells market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $23.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period is primarily driven by factors such as the increasing acceptance of personalized oncology diagnostics, growing investments in cancer biomarker research, the broader deployment of automated cell capture technologies, a rising need for tools capable of detecting cancer at early stages, and the expanding integration of artificial intelligence within oncology diagnostics. Key trends anticipated in this period encompass the increased application of liquid biopsy techniques, the rising embrace of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, the broader scope of oncology research applications, and a heightened emphasis on early cancer detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Drivers Are Shaping Future Opportunities In The Circulating Tumor Cells Market?

The expansion of the circulating tumor cells market is anticipated to be propelled by the increasing occurrence of cancer moving forward. Cancer is defined as a condition where certain body cells multiply uncontrollably and spread to other parts. Circulating tumor cells are instrumental in aiding the early detection and diagnosis of cancer, and thus, the rising incidence of cancer propels the growth of the circulating tumor cells market. For instance, in February 2024, the World Health Organization, an international organization based in Switzerland specializing in global health policy and public health initiatives, predicted over 35 million new cancer cases in 2050, which represents a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is driving the growth of the circulating tumor cells market.

Which Segments Are Gaining Traction In The Circulating Tumor Cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Trends Are Influencing The Performance And Direction Of The Circulating Tumor Cells Market?

Leading companies within the circulating tumor cells (CTC) market are concentrating on creating novel solutions, such as biomarker-specific CTC assays, to address the increasing need for accurate, non-invasive cancer diagnosis and sophisticated personalized therapy tracking. These biomarker-specific CTC assays facilitate the identification and characterization of circulating tumor cells through particular protein expression, providing richer phenotypic data compared to conventional CTC enumeration techniques, which primarily offer total cell counts without distinguishing biomarkers. As an illustration, in July 2023, Menarini Silicon Biosystems S.p.A., a diagnostics firm based in Italy, unveiled the CELLSEARCH CTC test incorporating the DLL3 biomarker, which is presently accessible as a Research Use Only (RUO) service across North America and Europe. This assay utilizes the FDA-cleared CELLSEARCH platform to identify circulating tumor cells that express DLL3, a protein frequently overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By concentrating on DLL3, the test enables the phenotypic characterization of CTCs associated with unfavorable prognoses, thereby assisting biopharma research in the development of targeted therapies. This innovation provides researchers with a non-invasive instrument to investigate tumor heterogeneity, track disease progression, and assess responses to targeted treatments.

Who Are The Core Companies Influencing Trends In The Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regions Are Projected To Dominate The Circulating Tumor Cells Market In The Coming Years?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Circulating Tumor Cells Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company